Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. / Goldrat, Oranite; Kroman, Niels; Peccatori, Fedro A; Cordoba, Octavi; Pistilli, Barbara; Lidegaard, Oejvind; Demeestere, Isabelle; Azim, Hatem A.

I: European journal of cancer (Oxford, England : 1990), Bind 51, Nr. 12, 08.2015, s. 1490-6.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Goldrat, O, Kroman, N, Peccatori, FA, Cordoba, O, Pistilli, B, Lidegaard, O, Demeestere, I & Azim, HA 2015, 'Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome', European journal of cancer (Oxford, England : 1990), bind 51, nr. 12, s. 1490-6. https://doi.org/10.1016/j.ejca.2015.05.007

APA

Goldrat, O., Kroman, N., Peccatori, F. A., Cordoba, O., Pistilli, B., Lidegaard, O., Demeestere, I., & Azim, H. A. (2015). Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. European journal of cancer (Oxford, England : 1990), 51(12), 1490-6. https://doi.org/10.1016/j.ejca.2015.05.007

Vancouver

Goldrat O, Kroman N, Peccatori FA, Cordoba O, Pistilli B, Lidegaard O o.a. Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. European journal of cancer (Oxford, England : 1990). 2015 aug.;51(12):1490-6. https://doi.org/10.1016/j.ejca.2015.05.007

Author

Goldrat, Oranite ; Kroman, Niels ; Peccatori, Fedro A ; Cordoba, Octavi ; Pistilli, Barbara ; Lidegaard, Oejvind ; Demeestere, Isabelle ; Azim, Hatem A. / Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome. I: European journal of cancer (Oxford, England : 1990). 2015 ; Bind 51, Nr. 12. s. 1490-6.

Bibtex

@article{71817d16afa14b06a02f4c0528dd6970,
title = "Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome",
abstract = "INTRODUCTION AND AIMS: We have previously shown that pregnancy is safe following breast cancer, even in endocrine sensitive disease. Yet infertility remains common following systemic treatment. To date, no study has evaluated the safety of assisted reproductive technology (ART) after breast cancer treatment. In this study, we evaluated the impact of ART on pregnancy and long-term outcomes of young breast cancer survivors.METHODS: This is a multi-centre retrospective study in which women who were diagnosed with breast cancer between 2000 and 2009, and had a pregnancy following breast cancer diagnosis were eligible. Patients were divided into two groups according to whether ART following primary systemic therapy was performed to achieve pregnancy. We evaluated the association between ART use and clinic-pathological characteristics, pregnancy outcome and long-term breast cancer outcome.RESULTS: A total of 198 patients were evaluated; of whom 25 underwent ART. No significant differences in tumour characteristics were observed between both groups, except for histological grade 3 tumours, which were fewer in the ART group (36% versus 59%, p=0.033). Around 90% of patients received primary adjuvant chemotherapy and more than 50% had an endocrine sensitive disease. Patients in the ART group were older at diagnosis (31.4 versus 33.7 years, p=0.009), at conception (38 versus 35 years, p<0.001), and experienced more miscarriages (23.5 versus 12.6%, p=0.082). Full term pregnancies were achieved in 77% and 76% of the spontaneous and ART groups, respectively. Mean follow-up between conception and last follow-up was 63 and 50 months in the spontaneous and ART groups, respectively with no difference in breast cancer outcome observed between the two groups (p=0.54).CONCLUSION: Pregnancy using ART in women with history of breast cancer is feasible and does not seem to be detrimental to cancer outcome. Larger studies are needed to further confirm this observation.",
keywords = "Adult, Breast Neoplasms, Feasibility Studies, Female, Humans, Middle Aged, Pregnancy, Pregnancy Outcome, Reproductive Techniques, Assisted, Retrospective Studies, Survivors, Young Adult",
author = "Oranite Goldrat and Niels Kroman and Peccatori, {Fedro A} and Octavi Cordoba and Barbara Pistilli and Oejvind Lidegaard and Isabelle Demeestere and Azim, {Hatem A}",
note = "Copyright {\textcopyright} 2015 Elsevier Ltd. All rights reserved.",
year = "2015",
month = aug,
doi = "10.1016/j.ejca.2015.05.007",
language = "English",
volume = "51",
pages = "1490--6",
journal = "European Journal of Cancer, Supplement",
issn = "0959-8049",
publisher = "Pergamon",
number = "12",

}

RIS

TY - JOUR

T1 - Pregnancy following breast cancer using assisted reproduction and its effect on long-term outcome

AU - Goldrat, Oranite

AU - Kroman, Niels

AU - Peccatori, Fedro A

AU - Cordoba, Octavi

AU - Pistilli, Barbara

AU - Lidegaard, Oejvind

AU - Demeestere, Isabelle

AU - Azim, Hatem A

N1 - Copyright © 2015 Elsevier Ltd. All rights reserved.

PY - 2015/8

Y1 - 2015/8

N2 - INTRODUCTION AND AIMS: We have previously shown that pregnancy is safe following breast cancer, even in endocrine sensitive disease. Yet infertility remains common following systemic treatment. To date, no study has evaluated the safety of assisted reproductive technology (ART) after breast cancer treatment. In this study, we evaluated the impact of ART on pregnancy and long-term outcomes of young breast cancer survivors.METHODS: This is a multi-centre retrospective study in which women who were diagnosed with breast cancer between 2000 and 2009, and had a pregnancy following breast cancer diagnosis were eligible. Patients were divided into two groups according to whether ART following primary systemic therapy was performed to achieve pregnancy. We evaluated the association between ART use and clinic-pathological characteristics, pregnancy outcome and long-term breast cancer outcome.RESULTS: A total of 198 patients were evaluated; of whom 25 underwent ART. No significant differences in tumour characteristics were observed between both groups, except for histological grade 3 tumours, which were fewer in the ART group (36% versus 59%, p=0.033). Around 90% of patients received primary adjuvant chemotherapy and more than 50% had an endocrine sensitive disease. Patients in the ART group were older at diagnosis (31.4 versus 33.7 years, p=0.009), at conception (38 versus 35 years, p<0.001), and experienced more miscarriages (23.5 versus 12.6%, p=0.082). Full term pregnancies were achieved in 77% and 76% of the spontaneous and ART groups, respectively. Mean follow-up between conception and last follow-up was 63 and 50 months in the spontaneous and ART groups, respectively with no difference in breast cancer outcome observed between the two groups (p=0.54).CONCLUSION: Pregnancy using ART in women with history of breast cancer is feasible and does not seem to be detrimental to cancer outcome. Larger studies are needed to further confirm this observation.

AB - INTRODUCTION AND AIMS: We have previously shown that pregnancy is safe following breast cancer, even in endocrine sensitive disease. Yet infertility remains common following systemic treatment. To date, no study has evaluated the safety of assisted reproductive technology (ART) after breast cancer treatment. In this study, we evaluated the impact of ART on pregnancy and long-term outcomes of young breast cancer survivors.METHODS: This is a multi-centre retrospective study in which women who were diagnosed with breast cancer between 2000 and 2009, and had a pregnancy following breast cancer diagnosis were eligible. Patients were divided into two groups according to whether ART following primary systemic therapy was performed to achieve pregnancy. We evaluated the association between ART use and clinic-pathological characteristics, pregnancy outcome and long-term breast cancer outcome.RESULTS: A total of 198 patients were evaluated; of whom 25 underwent ART. No significant differences in tumour characteristics were observed between both groups, except for histological grade 3 tumours, which were fewer in the ART group (36% versus 59%, p=0.033). Around 90% of patients received primary adjuvant chemotherapy and more than 50% had an endocrine sensitive disease. Patients in the ART group were older at diagnosis (31.4 versus 33.7 years, p=0.009), at conception (38 versus 35 years, p<0.001), and experienced more miscarriages (23.5 versus 12.6%, p=0.082). Full term pregnancies were achieved in 77% and 76% of the spontaneous and ART groups, respectively. Mean follow-up between conception and last follow-up was 63 and 50 months in the spontaneous and ART groups, respectively with no difference in breast cancer outcome observed between the two groups (p=0.54).CONCLUSION: Pregnancy using ART in women with history of breast cancer is feasible and does not seem to be detrimental to cancer outcome. Larger studies are needed to further confirm this observation.

KW - Adult

KW - Breast Neoplasms

KW - Feasibility Studies

KW - Female

KW - Humans

KW - Middle Aged

KW - Pregnancy

KW - Pregnancy Outcome

KW - Reproductive Techniques, Assisted

KW - Retrospective Studies

KW - Survivors

KW - Young Adult

U2 - 10.1016/j.ejca.2015.05.007

DO - 10.1016/j.ejca.2015.05.007

M3 - Journal article

C2 - 26070684

VL - 51

SP - 1490

EP - 1496

JO - European Journal of Cancer, Supplement

JF - European Journal of Cancer, Supplement

SN - 0959-8049

IS - 12

ER -

ID: 162639002